Skip to main content

Table 2 Association between MIAT polymorphisms and IS risk

From: lncRNA-MIAT rs9625066 polymorphism could be a potential biomarker for ischemic stroke

Polymorphisms

Controls, n = 310

HEW, Pa

IS patients, n = 320

HEW, Pb

OR (95%CI)

P

P(BH)

rs2157598

 

0.831

 

0.642

   

 AA

99 (31.9)

 

112 (35.0)

 

1.00(ref)

  

 AT

154 (49.7)

 

158 (49.4)

 

0.82 (0.53-1.26)

0.370

0.663

 TT

57 (18.4)

 

50 (15.6)

 

1.07 (0.60-1.93)

0.811

0.901

 A

352 (56.8)

 

382 (59.7)

 

1.00(ref)

  

 T

268 (43.2)

 

258 (40.3)

 

0.99 (0.75-1.31)

0.954

0.954

Dominant model

 AA

99 (31.9)

 

112 (35.0)

 

1.00(ref)

  

 TT + TA

211 (68.1)

 

208 (65.0)

 

0.88 (0.58-1.32)

0.530

0.663

Recessive model

 AA + TA

253 (81.6)

 

270 (84.4)

 

1.00(ref)

  

 TT

57 (18.4)

 

50 (15.6)

 

1.21 (0.71-2.04)

0.484

0.663

rs5761664

 

0.798

 

0.824

   

 CC

132 (42.6)

 

146 (45.6)

 

1.00(ref)

  

 CT

139 (44.8)

 

139 (43.4)

 

0.86 (0.57-1.31)

0.488

0.663

 TT

39 (12.6)

 

35 (10.9)

 

1.55 (0.80-2.99)

0.192

0.433

 C

403 (65.0)

 

431 (67.3)

 

1.00(ref)

  

 T

217 (35.0)

 

209 (32.7)

 

1.1 (0.82-1.47)

0.515

0.663

Dominant model

 CC

132 (42.6)

 

146 (45.6)

 

1.00(ref)

  

 TT + TC

178 (57.4)

 

174 (54.4)

 

0.97 (0.66-1.43)

0.876

0.922

Recessive model

 CC + TC

271 (87.4)

 

285 (89.1)

 

1.00(ref)

  

 TT

39 (12.6)

 

35 (10.9)

 

1.67 (0.90-3.12)

0.106

0.303

rs1894720

 

0.711

 

0.143

   

 GG

118 (38.1)

 

133 (41.6)

 

1.00(ref)

  

 GT

144 (46.5)

 

137 (42.8)

 

0.78 (0.51-1.19)

0.250

0.500

 TT

48 (15.5)

 

50 (15.6)

 

1.48 (0.82-2.68)

0.195

0.433

 G

380 (61.3)

 

403 (63.0)

 

1.00(ref)

  

 T

240 (38.7)

 

237 (37.0)

 

1.11 (0.83-1.47)

0.490

0.663

Dominant model

 GG

118 (38.1)

 

133 (41.6)

 

1.00(ref)

  

 TT + GT

192 (61.9)

 

187 (58.4)

 

0.91 (0.61-1.36)

0.656

0.772

Recessive model

 GG + GT

262 (84.5)

 

270 (84.4)

 

1.00(ref)

  

 TT

48 (15.5)

 

50 (15.6)

 

1.70 (0.98-2.93)

0.058

0.232

rs9625066

 

0.732

 

0.354

   

 CC

174 (56.1)

 

202 (63.1)

 

1.00 (ref)

  

 CA

118 (38.1)

 

101 (31.6)

 

0.55 (0.37-0.85)

0.006

0.040

 AA

18 (5.80)

 

17 (5.30)

 

0.39 (0.16-0.94)

0.036

0.180

 C

466 (75.2)

 

505 (78.9)

 

1.00 (ref)

  

 A

154 (24.8)

 

135 (21.1)

 

0.59 (0.42-0.82)

0.002

0.020

Dominant model

 CC

174 (56.1)

 

202 (63.1)

 

1.00 (ref)

  

 AA + CA

136 (43.9)

 

118 (36.9)

 

0.53 (0.35-0.80)

0.002

0.020

Recessive model

 CC + CA

292 (94.2)

 

303 (94.7)

 

1.00 (ref)

  

 AA

18 (5.80)

 

17 (5.30)

 

0.49 (0.21-1.16)

0.106

0.303

  1. OR odds ratio, represents a statistical measure comparing the probability of events occurring in two groups, HWE Hardy-Weinberg equilibrium, refers to the principle of stable genotype frequencies in a genetic population
  2. aControls group
  3. bIS patients group
  4. Adjusted by age, gender, diabetes mellitus, TG, TC, LDL-C and HDL-C; P(BH):P values corrected by Benjamin-Hochberg (B-H) method